NextGen Vaccines Holding ApS: Financial statements 2020
CVR: 38706721
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
NextGen Vaccines Holding ApS (CVR 38706721) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -335,061 and a net result of DKK -329,869 compared with DKK -26,401 the year before. Equity in the 2020 report amounted to DKK -25,974.
- Gross Profit
- DKK -335,061
- Profit/Loss
- DKK -329,869
- Equity
- DKK -25,974
- Total Assets
- DKK 101,617
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -335K | -330K | -26K | 0 |
| 2019 | - | -25K | -26K | 304K | - |
| 2018 | - | -24K | 43 | 330K | 0 |
Official annual report
How creditworthy is NextGen Vaccines Holding ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
NextGen Vaccines Holding ApS has published its annual report for 2019. Gross profit came to DKK -25,288, and the net result was DKK -26,401.
About NextGen Vaccines Holding ApS
NextGen Vaccines Holding ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2017. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Adam Frederik Sander Bertelsen. The board consists of Morten Agertoug Nielsen (chair), Adam Frederik Sander Bertelsen, Ali El-Salanti and Jacob Hjulmand. The company's owners include Ali El-Salanti, Morten Agertoug Nielsen and Adam Frederik Sander Bertelsen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -29,096 and a net result of DKK -51,555 compared with DKK 28,029,025 the year before. Equity in the 2025 report amounted to DKK 229,546.